ArticleFrontiers in endocrinology2025
Relationship between hemoglobin glycation index and Cushing's syndrome: a cross-sectional study in Chinese populations.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cushing's syndrome (CS) is a group of diseases that lead to multi-organ damage and even life-threatening conditions due to prolonged exposure of the organism to high cortisol levels. In clinical work, its screening and diagnosis process is cumbersome. In this study, we explored the relationship between hemoglobin glycation index (HGI) and Cushing's syndrome in the hope of assisting in the screening of the disease. Methods: This cross-sectional study included 344 hospitalized patients. Subjects were analyzed by collecting post-admission laboratory indicators. Binary logistic regression analysis was used to test the correlation between HGI and CS. All patients diagnosed with CS underwent a standardized diagnostic process. Results: Out of the total participants, 33 (9.6%) were diagnosed with CS. In the unadjusted model, the likelihood of subjects developing CS increased with increasing HGI (odds ratio: 1.59, 95% confidence interval: 1.11-2.30; P<0.05). In the fully adjusted model, the risk of CS increased by 265% for each standard deviation increase in HGI (95% confidence interval: 1.26-5.57; P<0.05). Based on receiver operating characteristic (ROC) curve analysis and Youden's index, the sensitivity and specificity of HGI for predicting CS were 75.8% and 55%, respectively (cutoff value: -0.1185; area under the curve: 0.664; P = 0.002). Conclusions: Higher levels of HGI are associated with the risk of developing CS and contribute to screening for CS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.